| Fresenius Kabi Oncology has reported a sales turnover of Rs 164.53 crore and a net profit of Rs 26.95 crore for the quarter ended Sep '12. | | For the quarter ended Sep 2011 the sales turnover was Rs 159.26 crore and net profit was Rs 45.40 crore. |
|
| | Quarterly Results of Fresenius Kabi Oncology | -------- in Rs. Cr. -------- |
|
| Sep '11 | | | Jun '12 | Sep '12 | | Sales Turnover | 159.26 | | | 133.49 | 164.53 | | Other Income | 0.43 | | | 0.48 | 0.50 | | Total Income | 159.69 | | | 133.97 | 165.03 | | Total Expenses | 140.53 | | | 111.16 | 116.52 | | Operating Profit | 18.73 | | | 22.33 | 48.01 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | 37.21 | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 19.16 | | | 22.81 | 48.51 | | Interest | 1.92 | | | -0.10 | 7.29 | | PBDT | 54.45 | | | 22.92 | 41.21 | | Depreciation | 5.96 | | | 6.16 | 6.40 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 48.49 | | | 16.76 | 34.81 | | Tax | 3.09 | | | 3.72 | 7.86 | | Net Profit | 45.40 | | | 13.04 | 26.95 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 2.87 | | | 0.82 | 1.70 | | Book Value | -- | | | -- | -- | | Equity | 15.82 | | | 15.82 | 15.82 | | Reserves | -- | | | -- | -- | | Face Value | 1.00 | | | 1.00 | 1.00 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
